Paper37511795
Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy.
Cornell I and 9 others. J Pers Med, 2023. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy. Papers, record 37511795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37511795
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32662130 | Primary Central Nervous System Lymphoma: Clinical Evaluation of Automated Segmentation on Multiparametric MRI Using Deep Learning. | J Magn Reson Imaging | 2021 | https://conductscience.org/library/papers/32662130 | PubMed |
| 2 | 33615224 | Extent of radiological response does not reflect survival in primary central nervous system lymphoma. | Neurooncol Adv | 2021 | https://conductscience.org/library/papers/33615224 | PubMed |
| 3 | 15955902 | Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15955902 | PubMed |
| 4 | 27341986 | Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment. | Clin Radiol | 2016 | https://conductscience.org/library/papers/27341986 | PubMed |
| 5 | 33560416 | Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). | Neuro Oncol | 2021 | https://conductscience.org/library/papers/33560416 | PubMed |
| 6 | 25794073 | Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions. | AJR Am J Roentgenol | 2015 | https://conductscience.org/library/papers/25794073 | PubMed |
| 7 | 19729544 | Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. | AJNR Am J Neuroradiol | 2010 | https://conductscience.org/library/papers/19729544 | PubMed |
| 8 | 11121466 | Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/11121466 | PubMed |
| 9 | 25802212 | Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain. | NMR Biomed | 2015 | https://conductscience.org/library/papers/25802212 | PubMed |
| 10 | 31597366 | Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31597366 | PubMed |
| 11 | 34185076 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. | Neuro Oncol | 2021 | https://conductscience.org/library/papers/34185076 | PubMed |
| 12 | 28108885 | Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. | Neurotherapeutics | 2017 | https://conductscience.org/library/papers/28108885 | PubMed |
| 13 | 12091680 | Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. | Radiology | 2002 | https://conductscience.org/library/papers/12091680 | PubMed |
| 14 | 36978676 | Radiomics-Based Machine Learning Model for Predicting Overall and Progression-Free Survival in Rare Cancer: A Case Study for Primary CNS Lymphoma Patients. | Bioengineering (Basel) | 2023 | https://conductscience.org/library/papers/36978676 | PubMed |
| 15 | 30888569 | Primary central nervous system lymphoma in patients with and without HIV infection: a multicenter study and comparison with U.S national data. | Cancer Causes Control | 2019 | https://conductscience.org/library/papers/30888569 | PubMed |
| 16 | 28427529 | Primary central nervous system lymphoma. | Crit Rev Oncol Hematol | 2017 | https://conductscience.org/library/papers/28427529 | PubMed |
| 17 | 24814181 | Primary central nervous system lymphoma and atypical glioblastoma: multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging. | Radiology | 2014 | https://conductscience.org/library/papers/24814181 | PubMed |
| 18 | 31997308 | Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B-cell lymphoma of the central nervous system - an international study of feasibility and efficacy in routine clinical practice. | Br J Haematol | 2020 | https://conductscience.org/library/papers/31997308 | PubMed |
| 19 | 33692222 | Texture Analysis in Brain Tumor MR Imaging. | Magn Reson Med Sci | 2022 | https://conductscience.org/library/papers/33692222 | PubMed |
| 20 | 22228634 | Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22228634 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42428147 | MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance. | Front Oncol | 2026 | https://conductscience.org/library/papers/42428147 | PubMed |
| 42394762 | MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell Transplant. | EJHaem | 2026 | https://conductscience.org/library/papers/42394762 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37511795
GET https://conductscience.org/api/papers/v1/37511795/references?page=2